EUVIMEDEUVIMED entdecken
Open Access · CC0

A novel assay to measure low-density lipoproteins binding to proteoglycans

Esmond N Geh iD, Debi K Swertfeger, Hannah Sexmith, Anna Heink, Pheruza Tarapore, John T Melchior, W Sean Davidson, Amy Sanghavi Shah

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0291632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Esmond N Geh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Cincinnati Children's Hospital Medical Center & the Department of Pediatrics, University of Cincinnati College of Medicine…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NHLBI NIH HHS, NIH, Procter Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The binding of low-density lipoprotein (LDL) to proteoglycans (PGs) in the extracellular matrix (ECM) of the arterial intima is a key initial step in the development of atherosclerosis. Although many techniques have been developed to assess this binding, most of the methods are labor-intensive and technically challenging to standardize across research laboratories. Thus, sensitive, and reproducible assay to detect LDL binding to PGs is needed to screen clinical populations for atherosclerosis risk.

Objectives

The aim of this study was to develop a quantitative, and reproducible assay to evaluate the affinity of LDL towards PGs and to replicate previously published results on LDL-PG binding.

Methods

Immunofluorescence microscopy was performed to visualize the binding of LDL to PGs using mouse vascular smooth muscle (MOVAS) cells. An in-cell ELISA (ICE) was also developed and optimized to quantitatively measure LDL-PG binding using fixed MOVAS cells cultured in a 96-well format.

Results

We used the ICE assay to show that, despite equal APOB concentrations, LDL isolated from adults with cardiovascular disease bound to PG to a greater extent than LDL isolated from adults without cardiovascular disease (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtherosclerosisAnimalsMiceLipoproteins, LDLProteoglycansApolipoproteins BProtein Binding

Substanzen

Lipoproteins, LDLProteoglycansApolipoproteins B

Autor:innen und Institutionen

  • Division of Endocrinology, Cincinnati Children's Hospital Medical Center & the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America.
  • Center for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio, United States of America.
  • Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
  • Department of Neurology, Oregon Health and Science University, Portland, Oregon, United States of America.

ORCID-Profile: Esmond N Geh

Förderung

  • NHLBI NIH HHS
  • NIH
  • Procter Scholarship

Zitieren

APA

Geh, E. N., Swertfeger, D. K., Sexmith, H., Heink, A., Tarapore, P., Melchior, J. T., Davidson, W. S., & Shah, A. S. (2024). A novel assay to measure low-density lipoproteins binding to proteoglycans. PLOS ONE. https://doi.org/10.1371/journal.pone.0291632

Vancouver

Geh EN, Swertfeger DK, Sexmith H, Heink A, Tarapore P, Melchior JT, et al. A novel assay to measure low-density lipoproteins binding to proteoglycans. PLOS ONE. 2024. doi:10.1371/journal.pone.0291632

BibTeX
@article{Geh2024,
  author = {Geh, Esmond N and Swertfeger, Debi K and Sexmith, Hannah and Heink, Anna and Tarapore, Pheruza and Melchior, John T and Davidson, W Sean and Shah, Amy Sanghavi},
  title = {A novel assay to measure low-density lipoproteins binding to proteoglycans},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0291632}
}
Kostenlos starten →